Title:
AGENT FOR PREVENTION AND/OR TREATMENT OF PSEUDOMONAS AERUGINOSA INFECTION
Document Type and Number:
WIPO Patent Application WO/2019/203260
Kind Code:
A1
Abstract:
Provided is a novel agent for the prevention and/or treatment of Pseudomonas aeruginosa infection. It was discovered that bacteria belonging to the genus Enterococcus can prevent and/or treat Pseudomonas aeruginosa infection. An agent for the prevention and/or treatment of Pseudomonas aeruginosa infection, the agent containing bacteria belonging to the genus Enterococcus. A medicine for the prevention and/or treatment of Pseudomonas aeruginosa infection, the medicine containing bacteria belonging to the genus Enterococcus. A food for the prevention and/or treatment of Pseudomonas aeruginosa infection, the food containing bacteria belonging to the genus Enterococcus.
More Like This:
Inventors:
KAWAGUCHI SUSUMU (JP)
KATO MIHO (JP)
KATO MIHO (JP)
Application Number:
PCT/JP2019/016441
Publication Date:
October 24, 2019
Filing Date:
April 17, 2019
Export Citation:
Assignee:
NUTRI CO LTD (JP)
International Classes:
A61K35/744; A23L33/135; A61P31/04
Foreign References:
| JP2002179580A | 2002-06-26 | |||
| JP2014513106A | 2014-05-29 | |||
| JP2018080756A | 2018-05-24 |
Other References:
GARCIA-CANO, ISRAEL ET AL.: "Antibacterial activity produced by Enterococcus spp. Isolated from an artisanal Mexican dairy product, Cotija cheese", FOOD SCIENCE AND TECHNOLOGY, vol. 59, 2014, pages 26 - 34, XP028862706
MONTEL MENDOZA ET AL.: "Characterization of a bacteriocin produced by enterococcus gallinarum CRL 1826 isolated from captive bullfrog: Evaluation of its mode of action against Listeria monocytogenes and gram-negatives", J BIOPROCESS BIOTECH, vol. 5, no. 8, 2015, pages 1 - 9, XP055649609
YAKUGAKU ZASSHI, vol. 113, 1992, pages 396 - 399
JOURNAL OF ANIMAL CLINICAL RESEARCH, vol. 3, 1994, pages 11 - 20
T. HIRAI ET AL.: "Therapeutic Effect of Non-remunerated Voluntary Blood Donation-derived Intravenous Human Immunoglobulin G (IVIG) on the Treatment of Experimental Bacterial Infections-II. Preventive Effect of IVIG on Experimental Pseudomonas aeruginosa Infection in Neutropenic Mice", CLINICAL PHARMACOLOGY AND THERAPY, vol. 16, no. 2, 2006, pages 141 - 149
See also references of EP 3782631A4
MONTEL MENDOZA ET AL.: "Characterization of a bacteriocin produced by enterococcus gallinarum CRL 1826 isolated from captive bullfrog: Evaluation of its mode of action against Listeria monocytogenes and gram-negatives", J BIOPROCESS BIOTECH, vol. 5, no. 8, 2015, pages 1 - 9, XP055649609
YAKUGAKU ZASSHI, vol. 113, 1992, pages 396 - 399
JOURNAL OF ANIMAL CLINICAL RESEARCH, vol. 3, 1994, pages 11 - 20
T. HIRAI ET AL.: "Therapeutic Effect of Non-remunerated Voluntary Blood Donation-derived Intravenous Human Immunoglobulin G (IVIG) on the Treatment of Experimental Bacterial Infections-II. Preventive Effect of IVIG on Experimental Pseudomonas aeruginosa Infection in Neutropenic Mice", CLINICAL PHARMACOLOGY AND THERAPY, vol. 16, no. 2, 2006, pages 141 - 149
See also references of EP 3782631A4
Attorney, Agent or Firm:
MAYAMA, Setsuko et al. (JP)
Download PDF:
Previous Patent: HEATING COOKER
Next Patent: INK ADHESION LAYER FORMING COMPOSITION, PRINTING PLATE, AND PRINTED MATTER MANUFACTURING METHOD USIN...
Next Patent: INK ADHESION LAYER FORMING COMPOSITION, PRINTING PLATE, AND PRINTED MATTER MANUFACTURING METHOD USIN...